Research suggests that shilajit may possess antioxidant, anti-inflammatory, and immune-modulating properties that are theoretically relevant to aging-related processes, with two key compounds — fulvic acid and dibenzo-α-pyrones — identified as likely contributors to these effects. A separate laboratory study found that fulvic acid can inhibit tyrosinase, an enzyme involved in oxidative browning processes, though this finding comes from a food science context and its relevance to human aging biology remains speculative. The available evidence consists primarily of narrative reviews drawing on animal studies, traditional medicine texts, and limited human trials rather than rigorous randomized controlled trials, and at least one review explicitly characterized the scientific evidence for shilajit's antioxidant and immune-modulating claims as weak and poorly documented. Overall, while the existing research is directionally supportive of further investigation, the lack of well-controlled human trials using standardized preparations means firm conclusions about shilajit's role in anti-aging cannot yet be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Safety and efficacy of shilajit (mumie, moomiyo). | Review | 2014 | Supports | 78 |
| Review on shilajit used in traditional Indian medicine. | Review | 2011 | Supports | 75 |
| Structural and inhibitory effects of fulvic and humic acids against tyrosinase. | Other | 2022 | Supports | 60 |